文献速递临床试验与 GCP

可穿戴经皮穴位电刺激手环治疗全身麻醉后中重度术后恶心呕吐的疗效:多中心随机对照试验研究方案

Efficacy of wearable transcutaneous electrical acupoint stimulation bracelet on moderate-to-severe postoperative nausea and vomiting in patients after general anesthesia: a study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2024-12-02

这项多中心随机对照试验计划在中国上海和天津的4家学术医院招募232例全身麻醉后发生中重度术后恶心呕吐的女性患者,按1:1随机分入可穿戴经皮穴位电刺激手环组或对照(模型手环+甲氧氯普胺10 mg)组,主要结局为干预2小时后中重度术后恶心呕吐的应答率,随访至干预后24小时。

要点

  • 研究对象为全身麻醉后已发生中重度术后恶心呕吐的女性患者。
  • TEAS组佩戴EmeTerm手环并注射生理盐水,对照组佩戴模型手环并注射甲氧氯普胺10 mg。
  • 主要结局为干预2小时后中重度术后恶心呕吐的应答率。

核心结论

  • 该试验旨在揭示可穿戴经皮穴位电刺激手环对已发生的中重度术后恶心呕吐的治疗效果,预期该手环能成为术后恶心呕吐临床治疗的有效补充,减少医疗支出并改善麻醉质量与患者满意度。

研究设计与样本

  • 多中心随机对照试验,计划在中国上海和天津的4家学术医院招募232例全身麻醉后发生中重度术后恶心呕吐的女性患者,按1:1随机分入经皮穴位电刺激组或对照组。

主要发现

  • 经皮穴位电刺激组佩戴EmeTerm手环并注射生理盐水,对照组佩戴模型手环并注射甲氧氯普胺10 mg。
  • 干预2小时后随访,未缓解者再次随机分入两组并接受交叉干预。
  • 主要结局为干预2小时后中重度术后恶心呕吐的应答率。
  • 次要结局包括干预后24小时内中重度术后恶心呕吐的复发率,以及初始干预不敏感人群在交叉干预2小时后中重度术后恶心呕吐的应答率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative nausea and vomiting (PONV) is the most common complication following general anesthesia. Currently, pharmaceutical therapy is the primary method of treatment, but it has reached a plateau, and it is accompanied by inherent adverse reactions and high costs. Stimulation of the wrist acupuncture point PC6 is recommended as an effective means of preventing PONV. Our previous study suggests that the wearable transcutaneous electrical acupoint stimulation (TEAS) bracelet can prevent PONV, but its effectiveness in treating moderate-to-severe PONV that has already occurred remains unknown. This trial aims to include female patients who have suffered from PONV after general anesthesia in real-world settings to investigate the therapeutic effect of the TEAS bracelet. METHODS: This trial will be conducted in Shanghai and Tianjin, China, with a total of 232 participants recruited from four academic hospitals. Participants will be randomly allocated into the TEAS group or the control group in a 1:1 ratio. Participants in the TEAS group will wear an EmeTerm bracelet and be injected with normal saline, while participants in the control group will wear a model bracelet and be injected with 10 mg of metoclopramide. Follow-up will be conducted 2 h later, and participants who do not experience relief will be randomly allocated into two groups and given cross-intervention. The primary outcome of the trial is the response rate of moderate-to-severe PONV after 2 h of intervention. Secondary outcomes include the recurrence rate of moderate-to-severe PONV within 24 h after intervention and the response rate of moderate-to-severe PONV at 2 h after cross-intervention in a population insensitive to the initial intervention. DISCUSSION: This multi-center randomized controlled trial aims to reveal the therapeutic effect of the wearable TEAS bracelet on PONV. It is expected that this bracelet will become an effective supplement for the clinical treatment of PONV, reducing medical expenditure and improving anesthesia quality and patient satisfaction. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400084329. Registered on May 14, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ding P, Zheng DY, Zhu HW, et al. Efficacy of wearable transcutaneous electrical acupoint stimulation bracelet on moderate-to-severe postoperative nausea and vomiting in patients after general anesthesia: a study protocol for a multicenter randomized controlled trial. Trials. 2024. PMID: 39748403. doi:10.1186/s13063-024-08650-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。